Goldman Sachs Group Inc Ideaya Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,758,133 shares of IDYA stock, worth $38.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,758,133
Previous 869,183 102.27%
Holding current value
$38.2 Million
Previous $27.5 Million 64.1%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$24.79 - $31.98 $22 Million - $28.4 Million
888,950 Added 102.27%
1,758,133 $45.2 Million
Q3 2024

Nov 14, 2024
BUY
$30.37 - $43.05 $5.84 Million - $8.28 Million
192,449 Added 28.44%
869,183 $27.5 Million
Q2 2024

Aug 13, 2024
BUY
$34.37 - $43.46 $8.86 Million - $11.2 Million
257,835 Added 61.55%
676,734 $23.8 Million
Q1 2024

May 15, 2024
BUY
$34.2 - $47.13 $4.81 Million - $6.63 Million
140,733 Added 50.59%
418,899 $18.4 Million
Q4 2023

Feb 13, 2024
SELL
$24.59 - $35.83 $3.49 Million - $5.08 Million
-141,856 Reduced 33.77%
278,166 $9.9 Million
Q3 2023

May 14, 2024
BUY
$21.07 - $29.77 $2.99 Million - $4.22 Million
141,856 Added 51.0%
420,022 $11.3 Million
Q3 2023

Nov 14, 2023
BUY
$21.07 - $29.77 $630,899 - $891,403
29,943 Added 7.68%
420,022 $11.3 Million
Q2 2023

May 14, 2024
BUY
$13.33 - $25.53 $2.64 Million - $5.06 Million
198,350 Added 103.45%
390,079 $9.17 Million
Q2 2023

Aug 14, 2023
BUY
$13.33 - $25.53 $2.64 Million - $5.06 Million
198,350 Added 103.45%
390,079 $9.17 Million
Q1 2023

May 14, 2024
BUY
$13.49 - $18.72 $416,814 - $578,410
30,898 Added 19.21%
191,729 $2.63 Million
Q1 2023

May 11, 2023
BUY
$13.49 - $18.72 $416,814 - $578,410
30,898 Added 19.21%
191,729 $2.63 Million
Q4 2022

May 14, 2024
BUY
$14.47 - $18.17 $710,621 - $892,328
49,110 Added 43.96%
160,831 $2.92 Million
Q4 2022

Feb 13, 2023
BUY
$14.47 - $18.17 $710,621 - $892,328
49,110 Added 43.96%
160,831 $2.92 Million
Q3 2022

May 14, 2024
BUY
$9.24 - $15.79 $99,145 - $169,426
10,730 Added 10.62%
111,721 $1.67 Million
Q3 2022

Nov 10, 2022
BUY
$9.24 - $15.79 $99,145 - $169,426
10,730 Added 10.62%
111,721 $1.67 Million
Q2 2022

May 14, 2024
SELL
$8.28 - $13.88 $1.47 Million - $2.46 Million
-177,175 Reduced 63.69%
100,991 $1.39 Million
Q2 2022

Aug 15, 2022
SELL
$8.28 - $13.88 $753,446 - $1.26 Million
-90,996 Reduced 47.4%
100,991 $1.39 Million
Q1 2022

May 16, 2022
BUY
$11.18 - $24.02 $978,048 - $2.1 Million
87,482 Added 83.71%
191,987 $2.15 Million
Q4 2021

Feb 14, 2022
BUY
$20.95 - $26.88 $1.02 Million - $1.31 Million
48,621 Added 87.0%
104,505 $2.47 Million
Q3 2021

Nov 10, 2021
BUY
$17.26 - $27.08 $964,557 - $1.51 Million
55,884 New
55,884 $1.42 Million

Others Institutions Holding IDYA

# of Institutions
213
Shares Held
79.9M
Call Options Held
39.6K
Put Options Held
24.1K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.04B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email